You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Exploring New Treatment Options for Relapsed/Refractory Hairy Cell Leukemia

  • Authors: Farhad Ravandi, MD; Ethel C. Estrada, MSN, RN, FNP-C, OCN
  • CME / ABIM MOC / CE Released: 12/20/2018
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 12/20/2019
Start Activity


Target Audience and Goal Statement

This activity is intended for hematologists/oncologists, nurses, pathologists, and emergency medicine physicians.

The goal of this activity is to increase clinicians’ knowledge about treatment approaches for managing hairy cell leukemia (HCL).

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Current approaches for managing patients with relapsed/refractory (R/R) HCL
    • Clinical trial data on emerging therapies for R/R HCL
  • Have greater competence related to
    • Selecting tailored therapy for a patient with R/R HCL
    • Team-based strategies for managing common drug-related adverse events that occur with R/R HCL therapies


Faculty

  • Farhad Ravandi, MD

    Professor and Chief
    Section of Developmental Therapeutics
    The University of Texas
    MD Anderson Cancer Center
    Houston, Texas

    Disclosures

    Disclosure: Farhad Ravandi, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Astellas Pharma, Inc.; AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb Company; Jazz Pharmaceuticals, Inc.; Orsenix
    Received grants for clinical research from: Amgen Inc.; Bristol-Myers Squibb Company; Orsenix; Seattle Genetics, Inc.; Xencor, Inc.

  • Ethel C. Estrada, MSN, RN, FNP-C, OCN

    Advanced Practice Registered Nurse
    The University of Texas
    MD Anderson Cancer Center
    Houston, Texas

    Disclosures

    Disclosure: Ethel C. Estrada, MSN, RN, FNP-C, OCN, has disclosed no relevant financial relationships.

Editor

  • Melinda Tanzola, PhD

    Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Melinda Tanzola, PhD, has disclosed no relevant financial relationships.

CME Reviewer / Nurse Planner

  • Amy Bernard, MS, BSN, RN-BC, CHCP

    Lead Nurse Planner, Medscape, LLC

    Disclosures

    Disclosure: Amy Bernard, MS, BSN, RN-BC, CHCP, has disclosed no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50  AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
    Aggregate participant data will be shared with commercial supporters of this activity.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    Contact This Provider

    For Nurses

  • Awarded 0.50 contact hour(s) of continuing nursing education for RNs and APNs; 0.50 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Exploring New Treatment Options for Relapsed/Refractory Hairy Cell Leukemia

Authors: Farhad Ravandi, MD; Ethel C. Estrada, MSN, RN, FNP-C, OCNFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME / ABIM MOC / CE Released: 12/20/2018

Valid for credit through: 12/20/2019

processing....

A Powerpoint version of the slides from this presentation
is available for use as a professional resource from Medscape Education.

  • Print